RT Journal Article
SR Electronic
T1 A differential effect of visual cortex tDCS on reading of English and Chinese in patients with central vision loss
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.24.22277956
DO 10.1101/2022.07.24.22277956
A1 Silva, A.E.
A1 Lyu, A.
A1 Leat, S.J.
A1 Khan, S.
A1 Labreche, T.
A1 Chan, J.C.H.
A1 Li, Q.
A1 Woo, G.C.
A1 Woo, S.
A1 Cheong, A.M.Y
A1 Thompson, B.
YR 2022
UL http://medrxiv.org/content/early/2022/07/25/2022.07.24.22277956.abstract
AB We report that visual cortex a-tDCS influences reading performance in individuals with macular degeneration differently depending on the writing system employed. This finding will help to guide the international development of vision rehabilitation programs for macular degeneration that may utilize non-invasive brain stimulation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04111068Funding StatementThis research is supported by CFI (34095), NSERC (RPIN-05394 and RGPAS-477166), and the Velux Stiftung Foundation (1188). This research is also supported by InnoHK and the Hong Kong SAR government. AES is supported by a Transformative Quantum Technologies postdoctoral fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committees of the University of Waterloo and The Hong Kong Polytechnic University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the study are available upon reasonable request, subject to the study Steering Group's decision.